TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Alkermes Plc (ALKS)

Healthcare Drug Manufacturers - Specialty & Generic
49.50 $
+1.1% vs. previous close
Closing price · As of: 3. Aug 2026

Alkermes Plc (ALKS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 2,530 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet ALKS
Tick rows to compare them in a chart (up to 4) 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
1,921 1,856 1,726 1,797 1,825 1,805 1,950 2,024 1,964 2,136 2,056 2,530
1,047 1,019 913 966 983 962 1,111 1,062 1,130 1,486 1,415 1,929
224 181 186 191 267 204 273 338 292 457 291 1,120
802 799 619 591 539 535 635 536 608 773 752 1,319
152 155 191 234 300 265 290 327 297 333 390 334
51 38 63 93 90 102 126 150 181 186 183 197
266 255 265 285 310 362 350 341 325 – – –
94 93 93 93 93 93 93 93 83 83 83 84
479 379 318 256 191 151 111 74 38 2.0 0.9 84
524 541 517 594 654 720 883 912 920 934 591 711
131 236 212 291 340 391 438 471 498 520 465 543
6.8 66 3.0 3.0 2.8 11 19 19 13 8.7 6.2 6.7
32 37 46 56 40 54 46 56 33 66 46 108
351 284 281 278 276 274 272 293 290 288 – –
1,397 1,314 1,209 1,203 1,171 1,085 1,067 1,113 1,044 1,203 1,465 1,819
-512 -739 -948 -1,044 -1,185 -1,382 -1,493 -1,541 -1,699 -1,344 -976 -735
145 149 151 153 155 157 159 161 164 170 169 169

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?